American Portfolios Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.31M | Sell |
27,922
-1,102
| -4% | -$91.1K | 0.1% | 212 |
|
|
2022
Q2 | $2.76M | Sell |
29,024
-1,644
| -5% | -$156K | 0.11% | 190 |
|
|
2022
Q1 | $3.61M | Sell |
30,668
-8,275
| -21% | -$974K | 0.12% | 171 |
|
|
2021
Q4 | $5.05M | Buy |
38,943
+5,431
| +16% | +$704K | 0.17% | 115 |
|
|
2021
Q3 | $3.79M | Buy |
33,512
+2,092
| +7% | +$237K | 0.14% | 140 |
|
|
2021
Q2 | $3.25M | Buy |
31,420
+174
| +0.6% | +$18K | 0.13% | 162 |
|
|
2021
Q1 | $2.61M | Buy |
31,246
+1,616
| +5% | +$135K | 0.11% | 175 |
|
|
2020
Q4 | $2.7M | Buy |
29,630
+1,198
| +4% | +$109K | 0.14% | 143 |
|
|
2020
Q3 | $2.27M | Buy |
28,432
+2,358
| +9% | +$188K | 0.13% | 155 |
|
|
2020
Q2 | $1.8M | Sell |
26,074
-2,030
| -7% | -$140K | 0.12% | 174 |
|
|
2020
Q1 | $1.77M | Sell |
28,104
-9,144
| -25% | -$575K | 0.15% | 144 |
|
|
2019
Q4 | $2.9M | Buy |
37,248
+12,087
| +48% | +$940K | 0.21% | 114 |
|
|
2019
Q3 | $1.84M | Sell |
25,161
-3,159
| -11% | -$232K | 0.15% | 141 |
|
|
2019
Q2 | $1.74M | Sell |
28,320
-3,009
| -10% | -$185K | 0.15% | 152 |
|
|
2019
Q1 | $2M | Buy |
31,329
+681
| +2% | +$43.4K | 0.19% | 114 |
|
|
2018
Q4 | $1.56M | Buy |
30,648
+28,500
| +1,327% | +$1.46M | 0.19% | 115 |
|
|
2018
Q3 | $125K | Buy |
2,148
+75
| +4% | +$4.35K | 0.01% | 747 |
|
|
2018
Q2 | $101K | Sell |
2,073
-321
| -13% | -$15.6K | 0.01% | 801 |
|
|
2018
Q1 | $111K | Buy |
2,394
+111
| +5% | +$5.16K | 0.02% | 710 |
|
|
2017
Q4 | $85.8K | Buy |
+2,283
| New | +$85.8K | 0.01% | 781 |
|